Development of Interstitial Lung Disease (ILD) in Patients With Severe SARS-CoV-2 Infection (COVID-19)
Clinical trial NCT04416100 · UNKNOWN
Trial details
- NCT number
- NCT04416100
- Sponsor
- Medical University Innsbruck
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2020-04-29
- Primary completion
- 2022-04-28
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.